What other biotechs are you guys looking at these days?
Analyst Mr. Riceen also put an $28 price target on SGEN. He predicted that the company will increase its earnings per share at an annual rate of 7 to 14 percent, slightly below the 15 percent he previously forecasted.
He also wrote last week it would finish at $23.12. He was off a penny. In today's letter he said SGEN will close Monday at $23.45. Being 87% right there are no guarantee's, but this guy is a Guru.